Bromfenac 0.09% vs Ketorolac 0.4% for Cyclosporine Induction Phase
| Status: | Completed |
|---|---|
| Conditions: | Ocular, Ocular |
| Therapuetic Areas: | Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 10/14/2017 |
| Start Date: | August 2007 |
| End Date: | August 2008 |
Bromfenac 0.09% vs. Ketorolac 0.4% During the Induction Phase of Treatment With Topical Cyclosporine for Chronic Dry Eye Patients
To compare bromfenac 0.09% and ketorolac 0.4% when used concomitantly with cyclosporine
ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of
treatment for chronic dry eye disease
ophthalmic emulsion 0.05% in improving patient comfort during the induction phase of
treatment for chronic dry eye disease
Inclusion Criteria:
- Must be in general good health
- Diagnosis of moderate to severe dry eye syndrome
Exclusion Criteria:
- Patients who are unlikely to respond to cyclosporine ophthalmic emulsion therapy
- Patients who are pregnant or nursing females
- Unwilling to discontinue use of contact lenses during the run-in and duration of the
study
- Presence or history of any systemic or ocular disorder or condition that could
possibly interfere with the interpretation of the study results in the study eye
- Previous treatment failure on CSA 0.05% (Restasis)
- Known hypersensitivity to any component of the study or procedural medications
- Participation in any other clinical trial within 30 days prior to screening
- Known contraindication to any study medication or any of their components.
- Should not be taking any oral anti-histamines, beta blockers or diuretics.
We found this trial at
1
site
Click here to add this to my saved trials
